Mini Review - (2023) Volume 14, Issue 5
Received: 02-Oct-2023, Manuscript No. jbsbe-23-117408;
Editor assigned: 04-Oct-2023, Pre QC No. P-117408;
Reviewed: 16-Oct-2023, QC No. Q-117408;
Revised: 21-Oct-2023, Manuscript No. R-117408;
Published:
30-Oct-2023
, DOI: 10.37421/2155-6210.2023.14.409
Citation: Gomez, Atit. “Probing Organoids and Organs-on-a-chip with Biosensors.” J Biosens Bioelectron 14 (2023): 409.
Copyright: © 2023 Gomez A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Organoids, spheroids and organs-on-a-chip are innovative three-dimensional cell culture models that mimic the structural and functional complexities of human tissues. They hold great promise in various fields, including drug development, disease modeling and regenerative medicine. To fully harness their potential, it is crucial to monitor and manipulate these 3D models effectively. Biosensors have emerged as powerful tools for probing organoids and organs-on-a-chip, offering real-time insights into cellular responses, metabolic activities and microenvironment dynamics. This paper explores the application of biosensors in studying 3D cell cultures, highlighting their role in advancing our understanding of tissue physiology, drug screening and disease modeling. The integration of biosensors with organoid and organs-on-a-chip technologies opens new avenues for personalized medicine and drug discovery, ultimately paving the way for more accurate and efficient in vitro models.
Biosensors • Organoids • Organs-on-a-chip • Spheroids • Tissue engineering
The development of three-dimensional cell culture models, including organoids, spheroids and organs-on-a-chip, represents a ground-breaking advance in the field of biomedical research. These models provide a closer approximation to the complexity and functionality of human tissues than traditional two-dimensional cell cultures. As a result, they have gained prominence in drug development, disease modelling and regenerative medicine [1]. However, to fully exploit their potential, it is essential to gain real-time insights into the cellular responses, metabolic activities and microenvironment dynamics within these 3D cultures. Biosensors have emerged as indispensable tools for probing organoids and organs-on-a-chip, offering the capability to monitor and manipulate these models effectively. This paper explores the multifaceted role of biosensors in the study of 3D cell cultures, emphasizing their contributions to advancing our understanding of tissue physiology, enabling more precise drug screening and enhancing disease modeling. The integration of biosensors with organoid and organson- a-chip technologies opens new frontiers in personalized medicine and drug discovery, thereby revolutionizing in vitro models [2].
The emergence of 3D cell culture models such as organoids, spheroids and organs-on-a-chip has transformed the landscape of biomedical research. These models more faithfully replicate the native tissue microenvironments and have found application in a variety of fields. To maximize their utility, researchers have recognized the need for real-time monitoring and analysis of the cellular behaviour, metabolic processes and microenvironmental conditions within these 3D cultures. In this context, biosensors have emerged as a vital component of experimental strategies [3]. These analytical devices can provide continuous and non-invasive measurement of various biochemical and biophysical parameters. Numerous studies have illustrated the utility of biosensors in probing organoids and organs-on-a-chip. They enable the assessment of cellular viability, metabolic activity and responses to external stimuli. Additionally, biosensors integrated into microfluidic systems have facilitated the precise control of microenvironmental conditions. Furthermore, biosensor technology has the potential to significantly impact disease modelling, offering researchers a more comprehensive understanding of disease progression and drug responses. The literature highlights the versatility and importance of biosensors in advancing the capabilities of 3D cell culture models and provides valuable insights into their integration for various applications [4].
Biosensors play a pivotal role in the study of organoids, spheroids and organs-on-a-chip, significantly enhancing our ability to understand and manipulate these 3D cell culture models. They offer several key advantages. First, biosensors provide real-time data, enabling the continuous monitoring of cellular behaviour and responses within the 3D cultures. This temporal information is invaluable in assessing the dynamics of tissue growth, response to external stimuli and metabolic activities. Second, biosensors offer non-invasive and label-free monitoring, reducing the perturbation of the biological system and allowing for long-term observations. Third, when integrated into microfluidic systems, biosensors enable precise control of the microenvironment, including factors such as nutrient availability, oxygen concentration and pH. This control is crucial for simulating specific physiological conditions and disease microenvironments. Moreover, the integration of biosensors has facilitated the development of biomimetic platforms for personalized medicine and drug screening. By incorporating patient-specific cells into organoid or organ-on-achip models and using biosensors for real-time assessment, researchers can tailor treatment strategies and predict drug responses more accurately [5,6].
In conclusion, the integration of biosensors with organoids, spheroids and organs-on-a-chip represents a significant advancement in the field of 3D cell culture models. Biosensors offer the capability to probe and manipulate these models with unprecedented precision, providing real-time insights into cellular responses, metabolic activities and microenvironment dynamics. The synergy between biosensors and 3D cell cultures has the potential to revolutionize multiple aspects of biomedical research, including drug development, disease modeling and regenerative medicine. By leveraging biosensor technology, we are moving closer to achieving more accurate and efficient in vitro models, ultimately contributing to advancements in personalized medicine and drug discovery. The application of biosensors in 3D cell culture research continues to evolve, promising new possibilities and breakthroughs in our understanding of complex biological systems.
None.
There are no conflicts of interest by author.
Biosensors & Bioelectronics received 1751 citations as per Google Scholar report